Goldman Sachs is out with its report today on Patterson Companies PDCO, raising its PT from $31 to $34.
In a note to clients, Goldman Sachs writes, "Our 12-month price target goes to $34 from $31, equally based on P/E and EBITDA) on model roll-forward and increased multiples as we have moved past an equipment promotion overhang. Our applied P/E multiple is now 16.8X from 14.1X prior, a premium to the five-year average and reflective of our positive view on the group."
Goldman Sachs maintains Neutral on PDCO.
Shares of PDCO closed Thursday at $35.11, down 0.06% from Wednesday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsGoldman SachsHealth CareHealth Care Distributorspatterson companies
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in